Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Intellectual Disability

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...

Cognitive Development During Adulthood

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

Language and Cognition

Language and Cognition

Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A cardiac intimal sarcoma mimicking infective endocarditis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2023

Same author

A novel DSP zebrafish model reveals training- and drug-induced modulation of arrhythmogenic cardiomyopathy phenotypes.

Cell death discovery·2023

Same author

Characteristics and Clinical Value of Electroanatomic Voltage Mapping in Cardiac Amyloidosis.

The Canadian journal of cardiology·2023

Same author

[2023 ESC Guidelines for the management of cardiomyopathies].

Giornale italiano di cardiologia (2006)·2023

Same author

Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.

International journal of cardiology·2023

Same author

Consensus statement on the processing, interpretation and reporting of temporal artery biopsy for arteritis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2023

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Cognitive impairment: classification and open issues.

Cristina Basso¹, Federica Limongi, Paola Siviero

¹CNR Aging Section, Institute of Neuroscience, Consiglio Nazionale delle Ricerche, Via Giustiniani 2, 35128 Padua, Italy.

Aging Clinical and Experimental Research

|November 17, 2007

Summary

This summary is machine-generated.

Cognitive impairment syndromes lack consistent definitions, leading to varied incidence and prevalence. Most cases may progress to Alzheimer Disease (AD), but conversion rates differ significantly across studies.

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Related Experiment Videos

Last Updated: Jul 10, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Area of Science:

Neurology
Epidemiology
Gerontology

Background:

Nondisabling symptomatic cognitive deficits are described by various clinical syndromes with inconsistent diagnostic criteria and nomenclature.
This heterogeneity leads to significant variability in reported incidence and prevalence rates of cognitive impairment.
Understanding these syndromes is crucial for accurate diagnosis and patient management.

Purpose of the Study:

To review and summarize existing definitions of clinically-defined cognitive impairment syndromes.
To present and analyze current epidemiological data, including incidence and prevalence rates.
To discuss the progression of cognitive impairment to Alzheimer Disease (AD).

Main Methods:

Systematic literature review of studies defining cognitive impairment syndromes.
Analysis of epidemiological data on incidence, prevalence, and conversion rates.
Examination of factors associated with cognitive impairment, such as age and genetics.

Main Results:

Significant variation exists in diagnostic criteria and nomenclature for cognitive impairment syndromes.
Cognitive impairment incidence increases with age, but associations with other risk factors remain inconsistent.
While many patients with cognitive impairment may progress to Alzheimer Disease (AD), conversion rates vary widely.

Conclusions:

Standardized definitions and diagnostic criteria for cognitive impairment are needed.
Further research is required to clarify the role of traditional risk factors in cognitive impairment.
Accurate epidemiological data is essential for understanding the burden and progression of cognitive impairment and Alzheimer Disease (AD).